Chemoinformaics analysis of 3,6,6,9-Bisepoxy-farnesa-1,7(14),10-triene
Molecular Weight | 234.339 | nRot | 2 |
Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
Exact Molecular Weight | 234.162 | nRing | 2 |
Solubility: LogS | -3.357 | nHRing | 2 |
Solubility: LogP | 3.54 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 41.3234 |
nHD | 0 | BPOL | 25.5426 |
QED | 0.677 |
Synth | 5.352 |
Natural Product Likeliness | 2.846 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.086 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.479 |
MDCK | 0.0000238 |
BBB | 0.464 |
PPB | 0.8473 |
VDSS | 1.682 |
FU | 0.121609 |
CYP1A2-inh | 0.057 |
CYP1A2-sub | 0.942 |
CYP2c19-inh | 0.199 |
CYP2c19-sub | 0.929 |
CYP2c9-inh | 0.054 |
CYP2c9-sub | 0.068 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.26 |
CYP3a4-inh | 0.535 |
CYP3a4-sub | 0.886 |
CL | 14.952 |
T12 | 0.174 |
hERG | 0.008 |
Ames | 0.921 |
ROA | 0.035 |
SkinSen | 0.303 |
Carcinogencity | 0.917 |
EI | 0.537 |
Respiratory | 0.338 |
NR-Aromatase | 0.109 |
Antiviral | Yes |
Prediction | 0.918452 |